Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viral Load Decline Kinetics with Ombitasvir/ABT-450/r + Dasabuvir +/- Ribavirin in HCV GT1a
NCT02493855Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Jun 2015
- Primary completion
- Apr 2016
- Modality
- Allosteric Modulators, Orthosteric Ligands
01
Overview
A Phase 2 trial of ombitasvir, paritaprevir, dasabuvir in hepatitis C virus infection, sponsored by AbbVie Inc.. Started Jun 2015; status: completed.
02
Drugs
ombitasvirparitaprevirdasabuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT02493855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02493855.